{"name":"Patrick Stiff","slug":"patrick-stiff","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxObG10LU9DRklsX3ZEMjRpQ2RoS2gzSV9Rd2l0REJSejdrdkhVMjY0alFfbjBaREJZUk1DTlpXcWdmV3pnTWNoek9rYXNkMUVoRGZyRjJwdDdoenJ1Y1RDcEc2U050MXpUSjBRUzk4TWt5NDZXZ2ZvYTNYQ2ItMVUwVm9qV3plRVpxcW80Smdnd04xNi1FbGZONUlKRGdVSUVhN18w?oc=5","date":"2026-03-17","type":"pipeline","source":"International Business Times UK","summary":"Pharma Executives Sentenced to Decades for $92M Black‑Market HIV Drug Scheme - International Business Times UK","headline":"Pharma Executives Sentenced to Decades for $92M Black‑Market HIV Drug Scheme","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxOS1NyWmpmSUlHS3lKQnM4T3RhOUtkdlNjV1lLTTB0MFJZbGo5dC1RRllNTUpwUXprb2hadnRnQ1hhOTM5TEp4Nm56SXN2bkxpM3pLVnhpOFBjUlNjalNiWWxpV2xBWkh5SUdiMVlZSWZyM25NN2JtQkxZZU9yazlmVXVjTmpBd0w3emdwRXdILV9mNlJrOG43SG5KSmtGT2pwTjA2U0Zwalh0SEN2aEJSQUExdDNwc2hOTTB6dnI4ZUdVemx4d2hzZnBicGR2WDFVeUdTalBrQ2MwRmphbTVKUFpLc3Y0N3NYSEE5YWZXamk?oc=5","date":"2026-01-30","type":"earnings","source":"Whalesbook","summary":"Strides Pharma PAT Jumps 131% on Asset Sale, Revenue Sees Modest Growth - Whalesbook","headline":"Strides Pharma PAT Jumps 131% on Asset Sale, Revenue Sees Modest Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxQa1kzbW9md250dWsxOWx2ZUVwbGtRZFl3VnRqSkRWZVZNRHUyTDJYWFB5U2x3ejdzdEVhekVlQVRkcjBHc1ZrWW5zU0UxcGp5dnVHTks2VXZXenRTQWtIVmg1QXFEd3hqYjV6aEQyVjRRMktuS3lpSmRDblBJbHMyMTZoY0xRY2R2UVF3cW5LRDNpMFNFSlRmbTZVSDFMOXZNaXE2M2lybllFcEVtbXVrTXMyb25HMnpOc05IUVA1MC1CQTRHaFl0MDVuWV9pLUp6MkhfNTZtenRtcXFKcE9TVzZCNkF3UQ?oc=5","date":"2026-01-20","type":"earnings","source":"Whalesbook","summary":"Senores Pharma Posts 105% PAT Surge on Diversified Revenue Mix - Whalesbook","headline":"Senores Pharma Posts 105% PAT Surge on Diversified Revenue Mix","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxOMkJ4U1pwaDNCRmV3S05FVUVicWdYcHFPR3NMSkVyU0V4dnVEa0ZFWFNxQWRCb0RTT2IxLXA1SnVfbl85RUs4anMwdW9PYU1YV3FsRWtyUjl1SGpwdlJBVFRVQ1A4cVFiRjNyWmhlTE5OLVMwc0Ixbl9XWURkV0VkWnJqVEQzRkdGNmkwRFZlTnIyMFVSN0JUaXh5Si1US3paVG9maVVOanZPeUxyQW1qRmdEMHVWU3VpRHIzMEVtQ2FMQl9JRG1zZFFMQWR5aXh1SjUyanZhenA2OVdud1dRT0hEaGR3RzlzbnpGWFNUMzA3d0lqb1A5WXJDTkVHd205Z0tnZG9maHZPaWdVa1dmZGxR?oc=5","date":"2025-12-17","type":"pipeline","source":"The Guardian Nigeria News","summary":"How purpose-driven innovation, standardised local manufacturing, promoting life-saving medicines, sustain May & Baker’s leadership in Nigeria’s healthcare sector - The Guardian Nigeria News","headline":"How purpose-driven innovation, standardised local manufacturing, promoting life-saving medicines, sustain May & Baker’s ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQRVFOYlFGX01JaDBiMWxxZEFFc0NFeVEwVUEyMFk3VjMtcXFBLUd3R0tWQS1NU29KRTlZN2Iwd3FKRWlGYzlKMkFqbGMzRGd6aU9mSHg0cHpvMkFka28tN3d0RVg0WUNKT3NnM00yOXN1MzMwVDdGQkxuNnEySVdCOWVTc1IwT3JwZUJyOGxKaExFWHVUWjY5dFFIbkpPUkU0enVKd1piOV92c2k1QnpmUU15LTFHam40WVR1bEkyVTdEd0JTdl9Yamh3?oc=5","date":"2025-09-25","type":"pipeline","source":"The Guardian","summary":"Moderna boss defends UK in drug-pricing row as he opens £150m Oxfordshire facility - The Guardian","headline":"Moderna boss defends UK in drug-pricing row as he opens £150m Oxfordshire facility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQSlRHb0ZrX3I0UXpaenBrOUFIUlZ1Zk5ndzU1ZUF5SThwM3JfU0ZWVTEyNFBEejUyWUZneFhRQU95UTJGa0toR2Jqb3BleFVJc0lnc2xZcUVkM1RncmZBWlJBc3h0dnRHODRzUTJKbWQzSkVMR3JndERZeVNMcWdSZzNsUkZ1RGM?oc=5","date":"2025-07-27","type":"deal","source":"The New York Times","summary":"U.S. Reaches Preliminary Trade Deal With Europe - The New York Times","headline":"U.S. Reaches Preliminary Trade Deal With Europe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2025-05-22","type":"earnings","source":"The Economic Times","summary":"Sun Pharma Q4 Results: Cons PAT falls 19% YoY to Rs 2,154 crore; Rs 5.5/share dividend announced - The Economic Times","headline":"Sun Pharma Q4 Results: Cons PAT falls 19% YoY to Rs 2,154 crore; Rs 5.5/share dividend announced","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxOUWFtdFAxWnFvaGNTZklZcjNIZTlJSU45UXlSdmdkcnBEOWtBSHdQU05aU0tMcU1XVUQ3NUpHYjlZRTBCLWZnZmFkeTlHM2otRGVHR0JEcTE5Wi1adXFhQTc3TE1QY3NjeDRpd29CeDhEcWpPbVBxcGFsOExzZzNYdGFPM3A3bzJBQ3U0ZWVqSEFJSzlmeHRxa1QtbUM2ekRxNmFjREU0UE1kdUdwZkc2LXY5dDAtbi0xZTZrRXlDbDFtNVRZWFNRNUlUVk1ncndVRFlIR9IB2gFBVV95cUxQZW43U3picldEUkJabERqYURGRmZDSkUxazA5N2dIVXFtZTFMNlREX0lhYVpoVlotbWNYMTJXWXhQM2xkZTd0aXZFRUJ3UXhpU3c3UUN1Q2drNC1TeFN2WXVxdjVCV3ZlVjlPUUZIdWFzVS1qSTQyS1FmZURxbEE2XzFHSDZhNzl4VWtmdUhIZjhSdlBveDhNMkVWVWY0MkxRNl9Uc0cwTHNXTVZLbzVheEVyZzVSTWJ3QS1Xa1FHRVBCZVdObmliV1BJYTRvRU1WYnFlYVFYTWVrQQ?oc=5","date":"2025-05-08","type":"earnings","source":"Business Standard","summary":"Dr Reddy's Q4 results preview: Analysts eye 18% jump in PAT; check details - Business Standard","headline":"Dr Reddy's Q4 results preview: Analysts eye 18% jump in PAT; check details","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNRG80LXNOc09VOFAzTE5TZ082WFdydTBWWlpkNlNvZVlhNjFyX29JTDN3SGthcW9ESFhOVnJya2l2NUtzTFZKb3FWdkxULTNITy0wbzQwNUFYSVhsN01mcTVaTm5Wb2trbmhPeU1OSEhCTi01ZmhBeHQtbHVVODUyT2FzeGZ3b29VTVB6WnB1Ymx0STQ?oc=5","date":"2024-08-10","type":"pipeline","source":"statnews.com","summary":"First Opinion readers respond to essays on right to try lies, pharma execs, and more - statnews.com","headline":"First Opinion readers respond to essays on right to try lies, pharma execs, and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOdWczdkpHY1k3UnduSTRiYnJpRDNLSzNjaHhJenpZNTNwcElOc0NBNzMtM0NtYXptb3dvMTFralJHbkVjLU1FNkIxMFVQMG04Zy1weEttdy16MXdrd2N6U1g0NndRUXVVTnh5aHp2N3oyUU5GN1B0bWFnYm1XdGpkNGFpTUdVR3V3WUxVY2Y0UWVtTXhXcjFEVEZKdlU?oc=5","date":"2021-05-21","type":"pipeline","source":"Hospice News","summary":"Voices: Patrick Leary, VP of Client Services, Enclara Pharmacia - Hospice News","headline":"Voices: Patrick Leary, VP of Client Services, Enclara Pharmacia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQajlZenBjaU5HMHZZYWpaRHFEMDRackNLaC1TaFNMdWZlMlBEN0NzX0NNWmlVMmpqNzRBZzFMZmpKVldGWnluQXNYaXlFbUVOUjljSERaWG9YMlBMN3plWTV1NUlPZThpd29kMFM5aTJSNWItZ3hhYXZpY3pYLTJMVDFZd3psSHF0bjlXbnBDOUp4b0s5ZnFjNFk2LXJmZlhXbkpWcE9tdzZFdw?oc=5","date":"2017-12-11","type":"trial","source":"healthcare-in-europe.com","summary":"CAR-T: Landmark cancer study sheds new light on immunotherapy - healthcare-in-europe.com","headline":"CAR-T: Landmark cancer study sheds new light on immunotherapy - healthcare-in","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE15VkhRQ1lPZFpRYVJwUGNITTF4MVU4SXQ3cjZRRlk2XzNOR0RGWUlfN0RDSTJkWHkzLXdjMUdHYUFKajQ0cXA5d3VyTU9TMVJZLVRXMVVoQ1hsMkV5TzZqeg?oc=5","date":"2017-12-10","type":"pipeline","source":"NEJM","summary":"Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma - NEJM","headline":"Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}